State Street Corp Takeda Pharmaceutical CO LTD Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $648,254 - $734,911	-47,877 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $12,458 - $15,514	-946 Reduced 1.94%	47,877 $653,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $45,819 - $48,517	-2,811 Reduced 5.44%	48,823 $800,000
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $198,583 - $223,661	-11,999 Reduced 18.86%	51,634 $869,000
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $65,720 - $78,266	3,933 Added 6.59%	63,633 $1.16 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $37,736 - $46,514	-2,452 Reduced 3.95%	59,700 $1.09 Million
Q3 2020 Nov 10, 2020	SELL	$17.1 - $19.19 $15,783 - $17,712	-923 Reduced 1.46%	62,152 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $212,255 - $283,686	14,548 Added 29.98%	63,075 $1.13 Million
Q1 2020 May 11, 2020	BUY	$13.02 - $20.31 $631,821 - $985,583	48,527 New	48,527 $737,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.